Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Visiongain | PRODUCT CODE: 1834915

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1834915

Clinical Trial Supply and Logistics Market for Pharma 2025-2035

PUBLISHED:
PAGES: 272 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5959.50
PDF (Team License - Up to 6 Users)
USD 7055.50
PDF (Site License)
USD 8288.50
PDF (Enterprise License - Includes Free Datasets)
USD 10473.65

Add to Cart

The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 10.1% by 2035.

The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Supply Chain Disruptions Pose Market Challenges

Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.

What would be the Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market?

The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.

Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the clinical trial supply and logistics for pharma market evolving?
  • What is driving and restraining the clinical trial supply and logistics for pharma market?
  • How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the clinical trial supply and logistics for pharma projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
  • Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:

  • Our 272-page report provides 115 tables and 129 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Type
  • CTS Manufacturing
  • CTS Logistics & Distribution
  • CT Supply Chain Management
  • CTS Packaging & Storage
  • Phase
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Post Launch

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • Almac Group
  • Bilcare Limited
  • Biocair
  • Catalent, Inc.
  • COREX Logistics
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • NAF Pharma
  • Oximio
  • Parexel International Corporation
  • PCI Pharma Services (PCI)
  • Royal Cargo
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway
  • Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035.
  • Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
  • How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?
  • In summary, our 270+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Clinical Trial Supply and Logistics Market for Pharma 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.
Product Code: PHA1374

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Move Towards Decentralized/Virtual Trials
      • 3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
      • 3.2.1.3 Growing Clinical Trials Volume
      • 3.2.1.4 Integrated Solution to Track Clinical Trials
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
      • 3.2.2.2 Man-made or Natural Disruption in Transportation
      • 3.2.2.3 High Financial Cost
    • 3.2.3 Market Opportunities
      • 3.2.3.1 AI and Machine Learning are Evolving with More Data
      • 3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
      • 3.2.3.3 Big Companies are driving the Market
  • 3.1 U.S. Tariffs: What's the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
    • 3.1.1 Overview
    • 3.1.2 V-Shaped Recovery Scenario
    • 3.1.3 Why V-Shaped Recovery?
      • 3.1.3.1 Impact from Tariffs
      • 3.1.3.2 Market Dynamics and Demand Recovery
      • 3.1.3.3 Policy and Funding Support
      • 3.1.3.4 Timeframe for Recovery
    • 3.1.4 U-Shaped Recovery Scenario
      • 3.1.4.1 Why U-Shaped Recovery?
      • 3.1.4.2 Impact from Tariffs
      • 3.1.4.3 Market Dynamics and Demand Recovery
      • 3.1.4.4 Policy and Funding Support
      • 3.1.4.5 Timeframe for Recovery
    • 3.1.5 L Shaped Recovery Scenario
      • 3.1.5.1 Why L-Shaped Recovery?
      • 3.1.5.2 Impact from Tariffs
      • 3.1.5.3 Market Dynamics and Demand Recovery
      • 3.1.5.4 Policy and Funding Support
      • 3.1.5.5 Timeframe for Recovery
    • 3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.1.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
    • 3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.2 Porter's Five Forces Analysis
    • 3.2.1 Bargaining Power of Suppliers
    • 3.2.2 Bargaining Power of Buyers
    • 3.2.3 Competitive Rivalry
    • 3.2.4 Threat of Substitutes
    • 3.2.5 Threat of New Entrants
  • 3.3 PEST Analysis

4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 4.4 CTS Manufacturing
    • 4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 CTS Logistics & Distribution
    • 4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)
  • 4.6 CT Supply Chain Management
    • 4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2025 & 2035 (%)
  • 4.7 CTS Packaging & Storage
    • 4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2025 & 2035 (%)

5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase

  • 5.1 Key Findings
  • 5.2 Phase Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 5.4 Preclinical
    • 5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Phase I
    • 5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Phase II
    • 5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Phase III
    • 5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Phase IV
    • 5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)
  • 5.9 Post Launch
    • 5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
    • 5.9.2 Market Share by Region, 2025 & 2035 (%)

6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis

8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • 11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
  • 11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
  • 11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
  • 11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
  • 11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

12 Company Profiles

  • 12.1 Catalent, Inc.
    • 12.1.1 Company Snapshot
    • 12.1.2 Company Overview
    • 12.1.3 Financial Analysis
      • 12.1.3.1 Net Revenue, 2020-2024
      • 12.1.3.2 Regional Market Shares, 2024
    • 12.1.4 Service Benchmarking
    • 12.1.5 Strategic Outlook
  • 12.2 Thermo Fisher Scientific Inc.
    • 12.2.1 Company Snapshot
    • 12.2.2 Company Overview
    • 12.2.3 Financial Analysis
      • 12.2.3.1 Net Revenue, 2020-2024
      • 12.2.3.2 R&D, 2020-2024
      • 12.2.3.3 Regional Market Shares, 2024
    • 12.2.4 Service Benchmarking
    • 12.2.5 Strategic Outlook
  • 12.3 ICON plc
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Financial Analysis
      • 12.3.3.1 Revenue, 2020-2024
      • 12.3.3.2 Regional Market Shares, 2023
    • 12.3.4 Service Benchmarking
    • 12.3.5 Strategic Outlook
  • 12.4 Eurofins Scientific
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Financial Analysis
      • 12.4.3.1 Net Revenue, 2019-2022
    • 12.4.4 Services Offered
    • 12.4.5 Strategic Outlook
  • 12.5 FedEx
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Financial Analysis
      • 12.5.3.1 Net Revenue, 2020-2024
      • 12.5.3.2 Regional Market Shares, 2024
    • 12.5.4 Service Benchmarking
  • 12.6 United Parcel Service, Inc.
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
      • 12.6.3.1 Net Revenue, 2020-2024
    • 12.6.4 Service Benchmarking
  • 12.7 Cencora, Inc.
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Financial Analysis
      • 12.7.3.1 Net Revenue, 2020-2024
    • 12.7.4 Service Benchmarking
  • 12.8 DHL Group
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Financial Analysis
      • 12.8.3.1 Net Revenue, 2020-2024
    • 12.8.4 Service Benchmarking
  • 12.9 DKSH Holding Ltd.
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Service Benchmarking
  • 12.10 KERRY LOGISTICS NETWORK LIMITED
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Financial Analysis
      • 12.10.3.1 Net Revenue, 2019-2023
      • 12.10.3.2 Regional Market Shares, 2024
    • 12.10.4 Service Benchmarking
  • 12.11 Kuehne+Nagel
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Financial Analysis
      • 12.11.3.1 Net Revenue, 2020-2024
      • 12.11.3.2 Regional Market Shares, 2024
    • 12.11.4 Service Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Bilcare Limited
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Service Benchmarking
  • 12.13 Mayne Pharma Group Limited
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Financial Analysis
      • 12.13.3.1 Net Revenue, 2020-2024
      • 12.13.3.2 Regional Market Shares, 2024
    • 12.13.4 Service Benchmarking
  • 12.14 Intertek Group plc
    • 12.14.1 Company Snapshot
    • 12.14.2 Company Overview
    • 12.14.3 Financial Analysis
      • 12.14.3.1 Net Revenue, 2020-2024
    • 12.14.4 Service Benchmarking
  • 12.15 Almac Group
    • 12.15.1 Company Snapshot
    • 12.15.2 Company Overview
    • 12.15.3 Service Benchmarking
    • 12.15.4 Strategic Outlook
  • 12.16 Parexel International Corporation
    • 12.16.1 Company Snapshot
    • 12.16.2 Company Overview
    • 12.16.3 Service Benchmarking
    • 12.16.4 Strategic Outlook
  • 12.17 Biocair
    • 12.17.1 Company Snapshot
    • 12.17.2 Company Overview
    • 12.17.3 Service Benchmarking
    • 12.17.4 Strategic Outlook
  • 12.18 Marken (A UPS Company)
    • 12.18.1 Company Snapshot
    • 12.18.2 Company Overview
    • 12.18.3 Service Benchmarking
  • 12.19 PCI Pharma Services (PCI)
    • 12.19.1 Company Snapshot
    • 12.19.2 Company Overview
    • 12.19.3 Service Benchmarking
    • 12.19.4 Strategic Outlook
  • 12.20 Movianto
    • 12.20.1 Company Snapshot
    • 12.20.2 Company Overview
    • 12.20.3 Service Benchmarking
  • 12.21 Yourway
    • 12.21.1 Company Snapshot
    • 12.21.2 Company Overview
    • 12.21.3 Service Benchmarking
  • 12.22 COREX Logistics
    • 12.22.1 Company Snapshot
    • 12.22.2 Company Overview
    • 12.22.3 Service Benchmarking
  • 12.23 Oximio
    • 12.23.1 Company Snapshot
    • 12.23.2 Company Overview
    • 12.23.3 Service Benchmarking
  • 12.24 Royal Cargo
    • 12.24.1 Company Snapshot
    • 12.24.2 Company Overview
    • 12.24.3 Service Benchmarking
  • 12.25 NAF Pharma
    • 12.25.1 Company Snapshot
    • 12.25.2 Company Overview
    • 12.25.3 Service Benchmarking

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players
Product Code: PHA1374

List of Tables

  • Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'V' Shaped Recovery
  • Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'U' Shaped Recovery
  • Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'L' Shaped Recovery
  • Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 6 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 11 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 12 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 13 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 14 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 15 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 16 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 18 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 21 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 22 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 23 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 26 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 27 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 28 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 29 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 30 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 31 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 32 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 33 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 34 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 37 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 38 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 39 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 40 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 41 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 42 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 43 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 44 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 47 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 48 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 49 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 50 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 51 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 52 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 53 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 54 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 55 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 56 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 57 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 58 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 59 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 60 Catalent, Inc.: Service Benchmarking
  • Table 61 Catalent, Inc.: Strategic Outlook
  • Table 62 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 63 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 64 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 65 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 66 ICON plc: Service Benchmarking
  • Table 67 ICON plc: Strategic Outlook
  • Table 68 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 69 Eurofins Scientific: Services Offered
  • Table 70 Eurofins Scientific: Strategic Outlook
  • Table 71 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 FedEx: Service Benchmarking
  • Table 73 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 74 United Parcel Service, Inc.: Service Benchmarking
  • Table 75 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Cencora, Inc.: Service Benchmarking
  • Table 77 DHL Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 DHL Group: Service Benchmarking
  • Table 79 DKSH Holding Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 DKSH Holding Ltd.: Service Benchmarking
  • Table 81 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 KERRY LOGISTICS NETWORK LIMITED: Service Benchmarking
  • Table 83 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 Kuehne+Nagel: Service Benchmarking
  • Table 85 Kuehne+Nagel: Strategic Outlook
  • Table 86 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 Bilcare Limited: Service Benchmarking
  • Table 88 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Mayne Pharma Group Limited: Service Benchmarking
  • Table 90 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Intertek Group plc: Service Benchmarking
  • Table 92 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Almac Group: Service Benchmarking
  • Table 94 Almac Group: Strategic Outlook
  • Table 95 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Parexel International Corporation: Service Benchmarking
  • Table 97 Parexel International Corporation: Strategic Outlook
  • Table 98 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Biocair: Service Benchmarking
  • Table 100 Biocair: Strategic Outlook
  • Table 101 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Marken (A UPS Company): Service Benchmarking
  • Table 103 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 PCI Pharma Services (PCI): Service Benchmarking
  • Table 105 PCI Pharma Services (PCI): Strategic Outlook
  • Table 106 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Movianto: Service Benchmarking
  • Table 108 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Yourway: Service Benchmarking
  • Table 110 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 COREX Logistics: Service Benchmarking
  • Table 112 Oximio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Oximio: Service Benchmarking
  • Table 114 Royal Cargo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Royal Cargo: Service Benchmarking
  • Table 116 NAF Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 NAF Pharma: Service Benchmarking

List of Figures

  • Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
  • Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
  • Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
  • Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
  • Figure 5 Clinical Trials Supply and Logistics Market: Market Dynamics
  • Figure 6 Clinical Trials Initiated by Phase, 2023
  • Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 10 Short Term & Long Term Planning
  • Figure 11 Impact of U.S. and China Trade War
  • Figure 12 Most Impacted Countries
  • Figure 13 Clinical Trial Supply and Logistics for Pharma Market: Porter's Five Forces Analysis
  • Figure 14 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
  • Figure 15 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
  • Figure 16 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 17 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 18 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 19 CTS Manufacturing Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 20 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 21 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 22 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 23 CT Supply Chain Management Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 24 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 25 CTS Packaging & Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 26 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
  • Figure 27 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 28 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025, 2030, 2035 (%)
  • Figure 29 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 30 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 32 Phase I Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 33 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 34 Phase II Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 35 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 36 Phase III Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 37 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 38 Phase IV Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 39 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 40 Post Launch Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 41 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
  • Figure 42 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2025, 2030, 2035 (%)
  • Figure 43 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 49 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 50 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 51 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
  • Figure 52 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 53 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 59 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 60 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 61 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
  • Figure 62 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 63 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 64 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 65 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 66 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 67 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 68 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 69 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 70 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 74 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 75 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 76 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 77 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 78 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
  • Figure 79 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 80 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 81 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 82 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 83 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 84 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 85 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 89 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 90 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 91 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 92 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 93 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
  • Figure 94 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 95 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 97 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
  • Figure 100 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 101 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 103 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 105 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
  • Figure 106 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
  • Figure 107 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 108 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 109 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 110 Catalent, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 111 Catalent, Inc.: Regional Market Shares, 2024
  • Figure 112 Thermo Fisher Scientific Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 113 Thermo Fisher Scientific Inc: R&D, 2020-2024 (US$ Million, AGR %)
  • Figure 114 Thermo Fisher Scientific Inc: Regional Market Shares, 2024
  • Figure 115 ICON plc: Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 116 ICON plc: Regional Market Shares, 2023
  • Figure 117 Eurofins Scientific: Net Revenue, 2019-2022 (US$ Million, AGR %)
  • Figure 118 FedEx: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 119 FedEx: Regional Market Shares, 2024
  • Figure 120 United Parcel Service, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 121 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 122 DHL Group: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 123 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 124 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2024
  • Figure 125 Kuehne+Nagel: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 126 Kuehne+Nagel: Regional Market Shares, 2024
  • Figure 127 Mayne Pharma Group Limited: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 128 Mayne Pharma Group Limited: Regional Market Shares, 2024
  • Figure 129 Intertek Group plc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!